Nicolas Barthelemy - Net Worth and Insider Trading

Nicolas Barthelemy Net Worth

The estimated net worth of Nicolas Barthelemy is at least $2 Million dollars as of 2024-09-23. Nicolas Barthelemy is the Director of Repligen Corp and owns about 4,668 shares of Repligen Corp (RGEN) stock worth over $667,384. Nicolas Barthelemy is the Director of Twist Bioscience Corp and owns about 13,939 shares of Twist Bioscience Corp (TWST) stock worth over $647,327. Nicolas Barthelemy is also the Director of Standard BioTools Inc and owns about 149,373 shares of Standard BioTools Inc (LAB) stock worth over $300,240. Besides these, Nicolas Barthelemy also holds 908 Devices Inc (MASS) , aTyr Pharma Inc (ATYR) . Details can be seen in Nicolas Barthelemy's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Nicolas Barthelemy has not made any transactions after 2024-06-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Nicolas Barthelemy

To

Nicolas Barthelemy Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Nicolas Barthelemy owns 4 companies in total, including Standard BioTools Inc (LAB) , Repligen Corp (RGEN) , and Twist Bioscience Corp (TWST) among others .

Click here to see the complete history of Nicolas Barthelemy’s form 4 insider trades.

Insider Ownership Summary of Nicolas Barthelemy

Ticker Comapny Transaction Date Type of Owner
LAB Standard BioTools Inc 2020-03-06 director
RGEN Repligen Corp 2024-06-14 director
TWST Twist Bioscience Corp 2022-05-11 director
LIMIT LIMIT 2021-06-24 director

Nicolas Barthelemy Latest Holdings Summary

Nicolas Barthelemy currently owns a total of 5 stocks. Among these stocks, Nicolas Barthelemy owns 4,668 shares of Repligen Corp (RGEN) as of June 14, 2024, with a value of $667,384 and a weighting of 40.05%. Nicolas Barthelemy owns 13,939 shares of Twist Bioscience Corp (TWST) as of May 11, 2022, with a value of $647,327 and a weighting of 38.85%. Nicolas Barthelemy also owns 149,373 shares of Standard BioTools Inc (LAB) as of March 6, 2020, with a value of $300,240 and a weighting of 18.02%. The other 2 stocks 908 Devices Inc (MASS) , aTyr Pharma Inc (ATYR) have a combined weighting of 3.08% among all his current holdings.

Latest Holdings of Nicolas Barthelemy

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
RGEN Repligen Corp 2024-06-14 4,668 142.97 667,384
TWST Twist Bioscience Corp 2022-05-11 13,939 46.44 647,327
LAB Standard BioTools Inc 2020-03-06 149,373 2.01 300,240
MASS 908 Devices Inc 2021-06-24 13,541 3.69 49,966
ATYR aTyr Pharma Inc 2010-12-10 708 1.86 1,317

Holding Weightings of Nicolas Barthelemy


Nicolas Barthelemy Form 4 Trading Tracker

According to the SEC Form 4 filings, Nicolas Barthelemy has made a total of 6 transactions in Repligen Corp (RGEN) over the past 5 years, including 1 buys and 5 sells. The most-recent trade in Repligen Corp is the acquisition of 1,200 shares on June 14, 2024, which cost Nicolas Barthelemy around $150,540.

According to the SEC Form 4 filings, Nicolas Barthelemy has made a total of 2 transactions in Twist Bioscience Corp (TWST) over the past 5 years, including 1 buys and 1 sells. The most-recent trade in Twist Bioscience Corp is the acquisition of 8,550 shares on May 11, 2022, which cost Nicolas Barthelemy around $250,088.

According to the SEC Form 4 filings, Nicolas Barthelemy has made a total of 2 transactions in Standard BioTools Inc (LAB) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Standard BioTools Inc is the acquisition of 80,000 shares on March 6, 2020, which cost Nicolas Barthelemy around $244,000.

More details on Nicolas Barthelemy's insider transactions can be found in the Insider Trading History of Nicolas Barthelemy table.

Insider Trading History of Nicolas Barthelemy

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Nicolas Barthelemy Trading Performance

GuruFocus tracks the stock performance after each of Nicolas Barthelemy's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Nicolas Barthelemy is 28.68%. GuruFocus also compares Nicolas Barthelemy's trading performance to market benchmark return within the same time period. The performance of stocks bought by Nicolas Barthelemy within 3 months outperforms 4 times out of 5 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Nicolas Barthelemy's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Nicolas Barthelemy

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
2 out of 4 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -7.87 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -3.2 LIMIT LIMIT LIMIT LIMIT LIMIT

Nicolas Barthelemy Ownership Network

Ownership Network List of Nicolas Barthelemy

No Data

Ownership Network Relation of Nicolas Barthelemy

Insider Network Chart

Nicolas Barthelemy Owned Company Details

What does Standard BioTools Inc do?

Who are the key executives at Standard BioTools Inc?

Nicolas Barthelemy is the director of Standard BioTools Inc. Other key executives at Standard BioTools Inc include director & 10 percent owner Casdin Partners Master Fund, L.p. , SVP & Chief Financial Officer Jeffrey G. Black , and director & 10 percent owner Eli Casdin .

Standard BioTools Inc (LAB) Insider Trades Summary

Over the past 18 months, Nicolas Barthelemy made no insider transaction in Standard BioTools Inc (LAB). Other recent insider transactions involving Standard BioTools Inc (LAB) include a net purchase of 10,798,445 shares made by Casdin Partners Master Fund, L.p. , a net purchase of 1,200,000 shares made by Eli Casdin , and a net purchase of 85,984 shares made by Jeffrey G. Black .

In summary, during the past 3 months, insiders sold 0 shares of Standard BioTools Inc (LAB) in total and bought 7,294,970 shares, with a net purchase of 7,294,970 shares. During the past 18 months, 0 shares of Standard BioTools Inc (LAB) were sold and 12,084,429 shares were bought by its insiders, resulting in a net purchase of 12,084,429 shares.

Standard BioTools Inc (LAB)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Standard BioTools Inc Insider Transactions

No Available Data

Nicolas Barthelemy Mailing Address

Above is the net worth, insider trading, and ownership report for Nicolas Barthelemy. You might contact Nicolas Barthelemy via mailing address: 1750 Bella Laguna Ct, Encinitas Ca 92024.

Discussions on Nicolas Barthelemy

No discussions yet.